Evaluation of Molecular Point-of-care Xpert ® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings
Condition: Screening of Patients With Symptoms Suggestive of SARS-CoV-2 Infection Intervention: Device: Gene Expert molecular Point-of-Care (POC) (Xpert® Xpress SARS-CoV-2/Flu/RSV test Sponsors: National Institute for Medical Research, Tanzania; University of Kinshasa (UNIKIN), Congo, The Democratic Republic of the ( Prof Vivi Maketa); Research Institute for Health Sciences - Burkina Faso, Burkina Faso (Dr Marc Christian Tahita); Universiteit Antwerpen, Belgium (ProfJean-P ierre Van geertruyden); Københavns Universitet (UCPH), Denmark (Prof Michael Alifrangis); Universidad de Valencia, Spain (Prof Fernando Gonzalez-Candelas) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Belgium Health | Burkina Faso Health | Congo Health | Denmark Health | Genetics | Research | SARS | Spain Health | Tanzania Health